TESSERA VENTURES
Tessera is an investment firm specialized in internet ventures and formed by entrepreneurs. They invest and incubate ventures in different stages and work with a selective portfolio approach. They prefer opportunities that come from the network, referred by someone they trust.
TESSERA VENTURES
Social Links:
Industry:
Business Development Venture Capital
Founded:
2009-01-01
Address:
Rio De Janeiro, Rio De Janeiro, Brazil
Country:
Brazil
Website Url:
http://www.tessera.ventures
Total Employee:
1+
Status:
Active
Technology used in webpage:
Domain Not Resolving Amazon
Similar Organizations
798 Ventures
798 Ventures is an investment and advisory firm that accelerates Brazilian startups inspired by Chinese business models.
D-Engine
D-Engine is an investment firm providing hands-on operational management support to venture companies.
Maxceed
Maxceed is an investment firm engaged in making capital investments mainly in biomedical and fintech companies of South-East Asia.
More informations about "Tessera Ventures"
Tessera Ventures - Crunchbase Investor Profile & Investments
Legal Name Tessera Ventures; Investor Type Venture Capital Tessera is an investment firm specialized in internet ventures and formed by entrepreneurs. They invest and incubate …See details»
Tessera Venture Partners - Crunchbase
Tessera Venture Partners is a venture fund focused on building the next frontier of digital companies. We invest in extraordinary founders with disruptive technologies in artificial intelligence and blockchain across FinTech, AdTech, …See details»
Tessera Venture Partners - LinkedIn
Tessera Venture Partners | 1,280 followers on LinkedIn. Tessera is an early stage venture fund investing in blockchain & AI companies across finance, media, and healthcare. | Tessera …See details»
Tessera Ventures - LinkedIn
Tessera Ventures | 745 followers on LinkedIn. Empresa de venture capital especializada em tecnologia e formada por empreendedores pioneiros na internet. | Tessera is a investment firm …See details»
Tessera Venture Partners - Products, Competitors, Financials, …
Tessera Venture Partners is a venture capital firm with a focus on early-stage investments in the technology sector. Use the CB Insights Platform to explore Tessera Venture Partners's full …See details»
Tessera Venture Partners - Funding, Financials, Valuation & Investors
Tessera Venture Partners has raised a total of $2.6M in a single venture fund, Tessera Venture Capital Fund. This fund was announced on Feb 9, 2018 and raised a total of . obfuscated. …See details»
Tessera Venture Partners Investments, Portfolio & Acquisitions
Tessera Venture Partners is an early-stage venture fund investing in transformative companies. The firm focuses on finance, media, and healthcare organizations. New York City, New York, …See details»
Tessera Venture Partners investment portfolio - PitchBook
Mar 17, 2022 Tessera Venture Partners General Information Company Description. Founded in 2018, Tessera Venture Partners is a venture capital firm based in New York, New York. The …See details»
Tessera Ventures investment portfolio | PitchBook
Tessera Ventures's latest investment was on 22-Sep-2022 in QR Capital (Asset Management), a company within the Asset Management industry. Data Transparency. Meet our data hygiene …See details»
Tessera Ventures Llp | Company Profile | The Company Check
Nov 28, 2023 Tessera Ventures Llp, established in 2022, is engaged in the Home Appliances sector in Salem. Explore their Corporate Structure, Financials, and More.See details»
Daniel Emilio Sabzehzar - CEO - The Org
Daniel Emilio Sabzehzar has a diverse work experience spanning various industries and roles. Daniel Emilio is currently the Managing Partner at Tesserakt Ventures, where they collaborate …See details»
Tessera Raises More Than $300 Million to Advance its Gene …
Apr 19, 2022 Investors included a wholly-owned subsidiary of the Abu Dhabi Investment Authority, Alaska Permanent Fund Corporation, Altitude Life Science Ventures, ARTIS …See details»
TESSERA VENTURES. LLC in Denver, CO | Company Info
Nov 8, 2024 TESSERA VENTURES. LLC is a Colorado Limited-Liability Company filed on June 15, 2000. The company's filing status is listed as Delinquent and its File Number is 20001120088. The Registered Agent on file for this company is Jerry L. Short and is located at 1550 Larimer St Ste 646, Denver, CO 80202. The company's principal address is 1550 Larimer ...See details»
Tessera - Crunchbase Company Profile & Funding
Tessera's vision is a world where anyone can have the opportunity to collectively own and govern things they value, without reliance on central gatekeepers to execute decisions and actions on ... Divergence Ventures Portfolio Companies . 46 Number of Organizations • $1B Total Funding Amount • 814 Number of Investors. Track . New York ...See details»
Tessera Therapeutics Announces Over $300M… | Flagship Pioneering
Apr 19, 2022 Latest Financing Round Will Support Tessera’s Build Out of its GENE WRITING Platforms and Pursuit of Multiple Therapeutic Programs for Clinical Development Somerville, …See details»
News - Tessera Therapeutics
May 11, 2024 By Tessera Therapeutics. 01.17.2023 | News JPM23: With preclinical gene writing data on display, Tessera CEO's spirits not dampened by California's wild weather From Fierce …See details»
Tessera Therapeutics | A Flagship Pioneering Company
Tessera Therapeutics is pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Our mission is …See details»
Elia Tessera - Nurse Practitioner, Woodbridge VA - HealthCare4PPL
Call Elia Tessera on phone number (703) 989-3169 for more information and advice or to book an appointment. 5523 Neddleton Ave, Woodbridge, VA 22193-4113 (703) 989-3169. Map and …See details»
Tessera Stock | Buy or Sell Shares | MicroVentures
Tessera's research and development efforts span various therapeutic areas, focusing on diseases that currently have limited or no treatment options. In addition to its innovative technology, Tessera collaborates with leading academic and industry partners to accelerate the development and commercialization of its therapies.See details»